Lumos Diagnostics Holdings Ltd

LDX

Company Profile

  • Business description

    Lumos Diagnostics Holdings Ltd is engaged in selling Products and providing Services to customers. Its product offering includes rapid, point-of-care diagnostic test products, mainly focused on the diagnosis and management of infectious diseases. Its product is FebriDx, a point-of-care test for detecting and differentiating viral and bacterial respiratory infections. Its Service offering includes contract research and development services specialising in innovation, development, manufacturing and commercialisation of point-of-care diagnostic test solutions. The Company has one operating segment, being the provision of point-of-care diagnostics goods and services. It operates in the United States and Australia, with the majority of revenue generated from the United States.

  • Contact

    2724 Loker Avenue West
    CarlsbadCA92010
    USA

    T: +1 855 586-6739

    https://www.lumosdiagnostics.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Devices

    Fiscal Year End

    Employees

Stocks News & Analysis

stocks

What a wobby AI trade could mean for Anthropic's IPO

Despite recent AI jitters, strategists expect strong demand for Anthropic’s potentially historic IPO.
stocks

Investor Playbook: What Transurban, APA and Deterra have in common?

What inflation-resistant businesses have in common.
stocks

Our view after REA’s share price rally

A bullish market reaction but valuation concerns remain.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,163.4018.700.20%
CAC 408,151.8612.860.16%
DAX 4025,953.05132.690.51%
Dow JONES (US)51,285.73237.33-0.46%
FTSE 10010,724.4850.540.47%
HKSE24,448.9532.91-0.13%
NASDAQ24,579.43264.431.09%
Nikkei 22558,775.501,340.732.33%
NZX 50 Index13,973.6224.88-0.18%
S&P 5007,376.8623.130.31%
S&P/ASX 2009,029.708.900.10%
SSE Composite Index3,660.7911.610.32%

Market Movers